-
1
-
-
84889872057
-
Development, maintenance and disruption of the blood-brain barrier
-
Obermeier B, Daneman R, Ransohoff RM (2013) Development, maintenance and disruption of the blood-brain barrier. Nature Med 19:1584-1596
-
(2013)
Nature Med
, vol.19
, pp. 1584-1596
-
-
Obermeier, B.1
Daneman, R.2
Ransohoff, R.M.3
-
2
-
-
84870408539
-
The blood-brain barrier in health and disease
-
Daneman R (2012) The blood-brain barrier in health and disease. Ann Neurol 72:648-672
-
(2012)
Ann Neurol
, vol.72
, pp. 648-672
-
-
Daneman, R.1
-
3
-
-
84876728629
-
Cellpenetrating peptide-mediated therapeutic molecule delivery into the central nervous system
-
Zou LL, Ma JL, Wang T et al (2013) Cellpenetrating peptide-mediated therapeutic molecule delivery into the central nervous system. Curr Neuropharmacol 11:197-208
-
(2013)
Curr Neuropharmacol
, vol.11
, pp. 197-208
-
-
Zou, L.L.1
Ma, J.L.2
Wang, T.3
-
4
-
-
84938084007
-
Absorptive-mediated endocytosis of cationized albumin and a P-endorphin- cationized albumin chimeric peptide by isolated brain capillaries
-
Kumagai AK, Eisenberg JB, Pardridge WM (1987) Absorptive-mediated endocytosis of cationized albumin and a P-endorphin- cationized albumin chimeric peptide by isolated brain capillaries. Biochem Biophys Res Commun 146: 307-313
-
(1987)
Biochem Biophys Res Commun
, vol.146
, pp. 307-313
-
-
Kumagai, A.K.1
Eisenberg, J.B.2
Pardridge, W.M.3
-
5
-
-
0033520487
-
In vivo protein transduction: Delivery of a biologically active protein into the mouse
-
Schwarze SR (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285:1569-1572
-
(1999)
Science
, vol.285
, pp. 1569-1572
-
-
Schwarze, S.R.1
-
6
-
-
40649085520
-
An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection
-
Lo SL, Wang S (2008) An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials 29: 2408-2414
-
(2008)
Biomaterials
, vol.29
, pp. 2408-2414
-
-
Lo, S.L.1
Wang, S.2
-
7
-
-
84884158801
-
Antisense gene silencing: Therapy for neurodegenerative disorders?
-
Nielsen TT, Nielsen JE (2013) Antisense gene silencing: therapy for neurodegenerative disorders? Genes 4:457-484
-
(2013)
Genes
, vol.4
, pp. 457-484
-
-
Nielsen, T.T.1
Nielsen, J.E.2
-
8
-
-
67649317011
-
Delivery of small interfering RNA (SiRNA) to the brain
-
Mathupala SP (2009) Delivery of small interfering RNA (siRNA) to the brain. Expert Opin Ther Pat 19:137-140
-
(2009)
Expert Opin Ther Pat
, vol.19
, pp. 137-140
-
-
Mathupala, S.P.1
-
9
-
-
34447114618
-
Transvascular delivery of small interfering RNA to the central nervous system
-
Kumar P, Wu H, McBride JL et al (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448: 39-43
-
(2007)
Nature
, vol.448
, pp. 39-43
-
-
Kumar, P.1
Wu, H.2
McBride, J.L.3
-
10
-
-
8544231403
-
Highly effi cient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation
-
Davidson TJ, Harel S, Arboleda VA et al (2004) Highly effi cient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation. J Neurosci 24:10040-10046
-
(2004)
J Neurosci
, vol.24
, pp. 10040-10046
-
-
Davidson, T.J.1
Harel, S.2
Arboleda, V.A.3
-
11
-
-
0034126420
-
New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy
-
Rousselle C, Clair P, Lefauconnier JM et al (2000) New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol Pharmacol 57:679-686
-
(2000)
Mol Pharmacol
, vol.57
, pp. 679-686
-
-
Rousselle, C.1
Clair, P.2
Lefauconnier, J.M.3
-
12
-
-
0035196836
-
Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: Saturation kinetics and specifi city
-
Rousselle C, Smirnova M, Clair P et al (2001) Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specifi city. J Pharmacol Exp Ther 296:124-131
-
(2001)
J Pharmacol Exp Ther
, vol.296
, pp. 124-131
-
-
Rousselle, C.1
Smirnova, M.2
Clair, P.3
-
13
-
-
0035984819
-
Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy
-
Rousselle C, Clair P, Temsamani J et al (2002) Improved brain delivery of benzylpenicillin with a peptide-vector-mediated strategy. J Drug Target 10:309-315
-
(2002)
J Drug Target
, vol.10
, pp. 309-315
-
-
Rousselle, C.1
Clair, P.2
Temsamani, J.3
-
15
-
-
34547642139
-
Blood-brain barrier transport of therapeutics via receptormediation
-
Jones AR, Shusta EV (2007) Blood-brain barrier transport of therapeutics via receptormediation. Pharm Res 24:1759-1771
-
(2007)
Pharm Res
, vol.24
, pp. 1759-1771
-
-
Jones, A.R.1
Shusta, E.V.2
-
17
-
-
48749095941
-
Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2
-
Demeule M, Currie JC, Bertrand Y et al (2008) Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem 106:1534-1544
-
(2008)
J Neurochem
, vol.106
, pp. 1534-1544
-
-
Demeule, M.1
Currie, J.C.2
Bertrand, Y.3
-
18
-
-
79955104821
-
Angiopepconjugated poly(Ethylene glycol)-co-poly(ε- caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma
-
Xin H, Jiang X, Gu J et al (2011) Angiopepconjugated poly(ethylene glycol)-co-poly(ε- caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 32:4293-4305
-
(2011)
Biomaterials
, vol.32
, pp. 4293-4305
-
-
Xin, H.1
Jiang, X.2
Gu, J.3
-
19
-
-
40849085422
-
Identifi cation and design of peptides as a new drug delivery system for the brain
-
Demeule M, Re A, Che C et al (2008) Identifi cation and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ther 324:1064-1072
-
(2008)
J Pharmacol Exp Ther
, vol.324
, pp. 1064-1072
-
-
Demeule, M.1
Re, A.2
Che, C.3
-
20
-
-
82055198586
-
Infl uence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1
-
Bertrand Y, Currie JC, Poirier J et al (2011) Infl uence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1. Br J Cancer 105:1697-1707
-
(2011)
Br J Cancer
, vol.105
, pp. 1697-1707
-
-
Bertrand, Y.1
Currie, J.C.2
Poirier, J.3
-
21
-
-
84863131334
-
Safety, pharmacokinetics, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paclitaxel, in patients with advanced solid tumors
-
Kurzrock R, Gabrail N, Chandhasin C et al (2012) Safety, pharmacokinetics, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paclitaxel, in patients with advanced solid tumors. Mol Cancer Ther 11:308-316
-
(2012)
Mol Cancer Ther
, vol.11
, pp. 308-316
-
-
Kurzrock, R.1
Gabrail, N.2
Chandhasin, C.3
-
22
-
-
84862777853
-
The targeteddelivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modifi ed with angiopep-2
-
Ren J, Shen S, Wang D et al (2012) The targeteddelivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modifi ed with angiopep-2. Biomaterials 33:3324-3333
-
(2012)
Biomaterials
, vol.33
, pp. 3324-3333
-
-
Ren, J.1
Shen, S.2
Wang, D.3
-
23
-
-
83355162386
-
The brain targeting mechanism of Angiopep-conjugated poly(Ethylene glycol)-co-poly(ε-caprolactone) nanoparticles
-
Xin H, Sha X, Jiang X et al (2012) The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles. Biomaterials 33:1673-1681
-
(2012)
Biomaterials
, vol.33
, pp. 1673-1681
-
-
Xin, H.1
Sha, X.2
Jiang, X.3
-
24
-
-
84865558062
-
Antiglioblastoma effi cacy and safety of paclitaxelloading Angiopep-conjugated dual targeting PEG-PCL nanoparticles
-
Xin H, Sha X, Jiang X et al (2012) Antiglioblastoma effi cacy and safety of paclitaxelloading Angiopep-conjugated dual targeting PEG-PCL nanoparticles. Biomaterials 33: 8167-8176
-
(2012)
Biomaterials
, vol.33
, pp. 8167-8176
-
-
Xin, H.1
Sha, X.2
Jiang, X.3
-
25
-
-
81155131290
-
Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome
-
Sun X, Pang Z, Ye H et al (2012) Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome. Biomaterials 33:916-924
-
(2012)
Biomaterials
, vol.33
, pp. 916-924
-
-
Sun, X.1
Pang, Z.2
Ye, H.3
-
26
-
-
70350200866
-
Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycolmodifi ed poly amidoamine dendrimer
-
Ke W, Shao K, Huang R et al (2009) Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycolmodifi ed poly amidoamine dendrimer. Biomaterials 30:6976-6985
-
(2009)
Biomaterials
, vol.30
, pp. 6976-6985
-
-
Ke, W.1
Shao, K.2
Huang, R.3
-
27
-
-
79960561767
-
Dual targeting effect of Angiopep-2-modifi ed, DNAloaded nanoparticles for glioma
-
Huang S, Li J, Han L et al (2011) Dual targeting effect of Angiopep-2-modifi ed, DNAloaded nanoparticles for glioma. Biomaterials 32:6832-6838
-
(2011)
Biomaterials
, vol.32
, pp. 6832-6838
-
-
Huang, S.1
Li, J.2
Han, L.3
-
28
-
-
84905494071
-
Angiopep-2 and activatable cell-penetrating peptide dualfunctionalized nanoparticles for systemic gliomatargeting delivery
-
Gao H, Zhang S, Cao S et al (2014) Angiopep-2 and activatable cell-penetrating peptide dualfunctionalized nanoparticles for systemic gliomatargeting delivery. Mol Pharm 11:2755-2763
-
(2014)
Mol Pharm
, vol.11
, pp. 2755-2763
-
-
Gao, H.1
Zhang, S.2
Cao, S.3
-
29
-
-
84899483274
-
Peptide-based delivery of oligonucleotides across blood-brain barrier model
-
Srimanee A, Regberg J, Hällbrink M et al (2013) Peptide-based delivery of oligonucleotides across blood-brain barrier model. Int J Pept Res Ther 20:169-178
-
(2013)
Int J Pept Res Ther
, vol.20
, pp. 169-178
-
-
Srimanee, A.1
Regberg, J.2
Hällbrink, M.3
-
30
-
-
84914159376
-
Novel target for peptide-based imaging and treatment of brain tumors
-
Hyvönen M, Enbäck J, Huhtala T et al (2014) Novel target for peptide-based imaging and treatment of brain tumors. Mol Cancer Ther 13:996-1007
-
(2014)
Mol Cancer Ther
, vol.13
, pp. 996-1007
-
-
Hyvönen, M.1
Enbäck, J.2
Huhtala, T.3
-
31
-
-
84873736834
-
A novel brain neurovascular unit model with neurons, astrocytes and microvascular endothelial cells of rat
-
Xue Q, Liu Y, Qi H et al (2013) A novel brain neurovascular unit model with neurons, astrocytes and microvascular endothelial cells of rat. Int J Biol Sci 9:174-189
-
(2013)
Int J Biol Sci
, vol.9
, pp. 174-189
-
-
Xue, Q.1
Liu, Y.2
Qi, H.3
-
32
-
-
33845966079
-
Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells
-
Brown RC, Morris AP, Neil RGO (2008) Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res 1130: 17-30
-
(2008)
Brain Res
, vol.1130
, pp. 17-30
-
-
Brown, R.C.1
Morris, A.P.2
Neil, R.3
-
33
-
-
84866644780
-
Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2
-
Dwyer J, Hebda JK, Le Guelte A et al (2012) Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2. PLoS One 7:e45562
-
(2012)
Plos One
, vol.7
-
-
Dwyer, J.1
Hebda, J.K.2
Le Guelte, A.3
|